Regions Financial Corp’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-9,511
| Closed | -$226K | – | 874 |
|
|
2019
Q4 | $226K | Buy |
9,511
+126
| +1% | +$2.99K | ﹤0.01% | 757 |
|
|
2019
Q3 | $258K | Sell |
9,385
-608
| -6% | -$16.7K | ﹤0.01% | 694 |
|
|
2019
Q2 | $330K | Sell |
9,993
-565
| -5% | -$18.7K | ﹤0.01% | 623 |
|
|
2019
Q1 | $370K | Buy |
10,558
+893
| +9% | +$31.3K | ﹤0.01% | 600 |
|
|
2018
Q4 | $321K | Buy |
9,665
+2,387
| +33% | +$79.3K | ﹤0.01% | 621 |
|
|
2018
Q3 | $366K | Buy |
7,278
+2,177
| +43% | +$109K | ﹤0.01% | 650 |
|
|
2018
Q2 | $306K | Sell |
5,101
-693
| -12% | -$41.6K | ﹤0.01% | 698 |
|
|
2018
Q1 | $266K | Sell |
5,794
-1,265
| -18% | -$58.1K | ﹤0.01% | 748 |
|
|
2017
Q4 | $281K | Sell |
7,059
-5,431
| -43% | -$216K | ﹤0.01% | 751 |
|
|
2017
Q3 | $500K | Sell |
12,490
-3,845
| -24% | -$154K | 0.01% | 629 |
|
|
2017
Q2 | $704K | Sell |
16,335
-19,173
| -54% | -$826K | 0.01% | 544 |
|
|
2017
Q1 | $1.11M | Sell |
35,508
-15,293
| -30% | -$478K | 0.01% | 479 |
|
|
2016
Q4 | $1.28M | Sell |
50,801
-19,364
| -28% | -$489K | 0.02% | 432 |
|
|
2016
Q3 | $1.74M | Sell |
70,165
-11,157
| -14% | -$276K | 0.02% | 328 |
|
|
2016
Q2 | $1.66M | Sell |
81,322
-6,722
| -8% | -$137K | 0.02% | 344 |
|
|
2016
Q1 | $1.34M | Sell |
88,044
-22,373
| -20% | -$341K | 0.02% | 422 |
|
|
2015
Q4 | $1.48M | Buy |
110,417
+26,407
| +31% | +$355K | 0.02% | 401 |
|
|
2015
Q3 | $1.18M | Buy |
+84,010
| New | +$1.18M | 0.02% | 456 |
|